Translational Advances in Pleural Disease - Types, Diagnosis and Treatment

Introduction

Pleural disease refers to a group of conditions that affect the pleura, a thin layer of tissue that surrounds the lungs and lines the inner wall of the chest cavity. Some common examples of the pleural disease include pleural effusion (adhesion of pleural layers), pneumothorax (collection in the layer in the pleura), and mesothelioma (a type of lung cancer). In addition, the pleural space is a potential site for fluid, blood, pus, or air accumulation, which can lead to various symptoms such as shortness of breath, chest pain, and difficulty breathing. This article will discuss recent translational advances in diagnosing and treating pleural disease.

What Are the Translational Advances in the Diagnosis of Pleural Disease?

Diagnosis of the pleural disease is essential in determining the appropriate course of treatment and management. In recent years, there have been several advances in the diagnostic techniques used to identify pleural disease. Some of the most notable advances include:

• Computed Tomography (CT) Scans - CT scans have long been the standard imaging method for diagnosing pleural disease. However, improvements in CT technology have made it possible to obtain higher-resolution images with less radiation exposure. Additionally, as mentioned earlier, using CT-guided pleural procedures has improved the ability to diagnose and treat pleural and malignant pleural effusions.

• Magnetic Resonance Imaging (MRI) - MRI is a non-invasive imaging technique that does not use ionizing radiation and can provide detailed images of the pleural space. It has helped detect small pleural effusions and differentiate between malignant and benign pleural lesions.

• Fluorodeoxyglucose-positron Emission Tomography (FDG-PET) - FDG-PET is a type of nuclear medicine imaging that uses a small amount of a radioactive tracer to produce images of metabolic activity within the body. It effectively identifies malignant pleural lesions and determines the mesothelioma stage, which can help guide treatment decisions.

• Thoracoscopy - Thoracoscopy is a minimally invasive diagnostic procedure that allows a surgeon to see the inside of the pleural cavity using a thoracoscope, a small camera inserted through a small incision in the chest wall. It can be used to obtain biopsies of pleural lesions and is a safe and effective diagnostic technique for pleural disease.

• Biomarkers - Biomarkers help diagnose pleural disease by measuring the level of specific molecules or genes in the blood or other bodily fluids. They are beneficial for detecting mesothelioma early, improving the chances of successful treatment. One example of a biomarker is a mesothelin-related protein (MRP) overexpressed in malignant pleural mesothelioma.

• Pleural Fluid Analysis - Analysis of pleural fluid can provide diagnostic information about the underlying cause of pleural disease. The fluid analyzes for protein content, glucose levels, pH, and more. For example, a high protein content and a low glucose level in the pleural fluid may indicate malignant effusion.

• Cytological Analysis - Cytological analysis of pleural fluid or pleural tissue samples can provide important diagnostic information about the underlying cause of pleural disease. Cytological analysis can detect the presence of malignant cells, aiding in diagnosing malignant pleural mesothelioma and other cancers affecting the pleura.

• Gene Expression Profiling - Gene expression profiling is a technique used to analyze the gene expression pattern in pleural tissue samples. It helps differentiate between benign and malignant pleural tumors and identify specific genetic mutations that can help guide treatment decisions.

• Proteomic Analysis - Proteomic analysis is a technique that identifies and quantifies specific proteins in pleural tissue samples. This can aid in diagnosing pleural disease, as different types of pleural disease may have distinct protein profiles.

• Bronchoscopy - Bronchoscopy is a procedure that involves the insertion of a flexible tube with a camera and light on the end into the patient's airway, which can allow the physician to examine the lungs, pleura, and airways. It can help diagnose a pleural disease that affects the airways, such as pneumothorax, pleural effusion, or pleural thickening.

• Positron Emission Tomography-Computed Tomography (PET-CT) - This imaging technique combines the metabolic information provided by PET with the anatomic information provided by CT. It helps identify malignant pleural lesions, determine the stage of mesothelioma, and identify the spread of the disease to other organs.

• Single Photon Emission Computed Tomography (SPECT) - This imaging technique uses a small amount of a radioactive tracer to produce images of lung function and perfusion. It helps identify pleural thickening and also in evaluating the effectiveness of therapy.

• Magnetic Resonance Imaging-Percussion (MRI-P) - This imaging technique uses MRI to evaluate pleural thickening and pleural effusions. The patient allows to cough or perform other lung maneuvers, which allows for assessing lung movement and chest wall mechanics.

• Functional Respiratory Imaging (FRI) - FRI is a non-invasive imaging technique that uses ultrasound to evaluate lung function and pleural thickening. This technique is beneficial for monitoring patients with pleural disease over time, as it allows for assessing lung function, pleural thickening, and pleural effusions.

• Endoscopic Ultrasound (EUS) - This imaging technique allows the physician to evaluate pleural thickening, pleural effusions, and lymph nodes, as well as to obtain biopsies of pleural lesions.

What Are the Translational Advances in the Treatment of Pleural Disease?

In recent years, treatment for pleural disease has seen significant advances, with new therapies and techniques improving patient outcomes. Some of the most notable advances include:

• Chemotherapy - Several new chemotherapy drugs to treat malignant pleural mesotheliomas, such as Pemetrexed and Cisplatin, to improve survival in mesothelioma patients. In addition, new combination therapies of traditional chemotherapy and newer agents give promising results.

• Immunotherapy - Immunotherapy is a cancer treatment that uses the body's immune system to fight cancer. Nivolumab is an example of immunotherapy that has shown promise in treating pleural mesothelioma. Nivolumab is an immunotherapy drug that effectively treats mesothelioma by boosting the immune system's ability to fight cancer cells.

• Targeted Therapies - Targeted therapies are drugs targeting the genetic mutations or protein over-expression of cancer cells, causing minimal damage to normal cells. They are instrumental in treating malignant pleural mesothelioma, as this type of cancer is known to have a high degree of genetic heterogeneity.

• Minimally Invasive Surgery - Thoracoscopic surgery, a minimally invasive surgical technique, has become more prevalent in recent years. This technique allows the surgeon to access the pleural space through small incisions in the chest wall, making it less invasive and painful than traditional thoracotomy.

• Imaging-guided Pleural Procedures - Imaging-guided pleural procedures have improved the management of pleural effusions. Ultrasound-guided pleural practices are safe and effective in managing pleural effusions. In addition, newer indwelling pleural catheters allow for continuous drainage of pleural effusion over an extended period.

• Gene Therapy - Genetic advancements have also led to new ways to treat pleural disease. Gene therapies introduce healthy copies of genes or disrupt the function of cancer-causing genes to treat the condition. Research in this area is ongoing, but early results are encouraging.

• Radiotherapy - Radiotherapy uses high-energy radiation to kill cancer cells. It treats pleural mesothelioma alone or in combination with chemotherapy. Advances in radiotherapy, such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), have improved the ability to deliver higher doses of radiation to the tumor while minimizing exposure to normal tissue.

• Photodynamic Therapy (PDT) - Photodynamic therapy uses a particular drug and light to destroy cancer cells. The drug is injected into the patient's bloodstream, and cells will take the drug. When a specific wavelength of light is exposed to the drug, it produces a chemical reaction that kills the cancer cells. This technique has been used to treat malignant pleural mesothelioma and is a less invasive alternative to surgery.

• Gene Therapy - Gene therapy is a relatively new approach to treating pleural disease. The idea behind gene therapy is to introduce healthy copies of genes or to disrupt the function of cancer-causing genes. It is still in the early stages of research, but early results are encouraging.

• Pleural Decortication - Decortication is a surgical procedure that involves removing the layer of tissue that lines the inside of the chest cavity (the pleura) and can be used to treat pleural thickening caused by pleural effusions, lung collapse, or malignancy.

• Pleurectomy or Decortication - This procedure involves removing the pleura layer that lines the chest inside and removing the cancerous tissue from the pleura and the diaphragm.

Conclusion

In conclusion, many recent translational advances occurred in diagnosing and treating pleural disease. These developments have improved the ability to diagnose pleural illness and led to more accurate and earlier diagnoses. The use of these techniques allows for more specific diagnoses, which in turn results in better treatment outcomes. Furthermore, these techniques have minimized the need for more invasive procedures, making diagnosis less painful and less costly for patients. All these new treatments have improved the ability to manage the pleural disease and provided alternative options for patients who may not be suitable for traditional therapies. Additionally, these treatments are associated with fewer side effects, shorter recovery times, and improved quality of life for patients. However, it is essential to note that these treatments are unsuitable for every patient, and the treatment options depend upon the individual's specific condition, stage, and overall health.